We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Healthcare AI Market to Reach USD 19.3 Billion By 2025

By HospiMedica International staff writers
Posted on 28 Sep 2017
The global healthcare artificial intelligence (AI) market will reach USD 19.3 billion by 2025, as medical image analysis, virtual assistants for patients, patient data processing, and 18 other key use cases will drive large deployments of AI in the healthcare industry. More...
These are the latest findings of Tractica (Boulder, CO, USA), a market intelligence firm that focuses on human interaction with technology.

Over the past several years, healthcare has witnessed a transformation with a shift from paper-based records systems to electronic records, and incorporation of digital health monitoring devices and other advanced patient screening systems. These advances have resulted in a data explosion, which can best be manipulated and analyzed using AI technology.

According to Tractica, AI is being mainly implemented as a tool to more efficiently and accurately review data, and uncover patterns in the data that can be used to improve analyses, uncover inefficiencies, and streamline care, from both the clinical and an operational perspective. The key driver of these AI implementations is to provide better care for patients, while reducing costs and administrative headaches and bottlenecks. Tractica forecasts global software revenue from 21 key healthcare AI use cases to grow from USD 165 million in 2017 to USD 5.6 billion annually by 2025, with hardware and services sales driven by these software implementations expected to boost the total revenue opportunity for the healthcare AI market.

“Controlling and reducing cost is a major driver of many healthcare initiatives, and the incorporation of AI technology is no exception,” said Tractica’s principal analyst Keith Kirkpatrick. “AI applications generally are designed to address specific, real-world use cases that make the diagnosis, monitoring, and treatment of patients more efficient, accurate, and available to populations around the world.”

Related Links:
Tractica


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Syringes
Prefilled Saline Flush Syringes
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.